Both in Biotechnology
Neurocrine Biosciences vs ImmunityBio
Over the past year NBIX returned −2.0% and IBRX returned +224.4%; their daily moves had a correlation of 0.18.
NBIX −2.0% IBRX +224.4%Growth of $1, one year, split-adjusted
| Metric | NBIX | IBRX |
|---|---|---|
| Price | $146.00 | $8.63 |
| Market cap | $14.84B | $9.15B |
| Today | +0.09% | +10.50% |
| 1 month | +4.0% | +1.3% |
| 6 months | +14.0% | +24.0% |
| Year to date | +2.9% | +335.9% |
| 1 year | +1.4% | +249.4% |
| Revenue growth (YoY) | +39.5% | +93.9% |
| Gross margin | 97.6% | 99.4% |
| Net margin | 15.1% | −449.6% |
| P/E (TTM) | 21.0× | — |
| Price / sales | 4.4× | 55.2× |
| Net cash | $389.8M | -$57.7M |
| Dividend yield | — | — |
| Volatility (60d) | 26.9% | 67.7% |
| Short % of float | 6.6% | 31.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).